TUBE PHARMACEUTICALS GMBH has a total of 18 patent applications. Its first patent ever was published in 2010. It filed its patents most often in EPO (European Patent Office), United States and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are SICHUAN BAILI PHARMACEUTICAL CO LTD, RQX PHARMACEUTICALS INC and IGENICA BIOTHERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | United States | 3 | |
#3 | Canada | 2 | |
#4 | China | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 2 | |
#6 | Australia | 1 | |
#7 | Israel | 1 | |
#8 | Republic of Korea | 1 | |
#9 | Singapore | 1 | |
#10 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Peptides | |
#3 | Medical preparations | |
#4 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Richter Wolfgang | 17 |
Publication | Filing date | Title |
---|---|---|
TW202034914A | Oral bendamustine formulations | |
WO2019068904A1 | Oral bendamustine formulations | |
WO2015113760A1 | Cytotoxic tubulysin compounds for conjugation | |
EP2499152A1 | Tubulin inhibitors |